Keywords:
COPD; airflow limitation; GOLD; platelet-to-lymphocyte ratio; systemic immune-inflammation index; NLR; complete blood count; biomarkers.References
1. Ellingsen J, et al. NLR, eosinophils and COPD outcomes (discussion of evidence/heterogeneity). 2021.
2. Fang L, et al. Meta-analysis: NLR and all-cause mortality in COPD. 2025.
3. Fu Y, et al. Biomarkers (NLR, PLR, SII) for frequent COPD exacerbations. 2025.
4. Global Initiative for Chronic Obstructive Lung Disease. GOLD 2025 Report (v1.0, 15 Nov 2024).
5. Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable COPD. 2008.
6. Kumar P, Lawrie C, Sriram KB. PLR and 90-day mortality in acute exacerbation of COPD. 2017.
7. Leuzzi G, Galeone C, Taverna F, et al. C-reactive protein level predicts mortality in COPD. Eur Respir Rev. 2017.
8. Li D, et al. Peripheral blood inflammatory markers (SII/NLR/PLR) and AECOPD severity/readmission. 2025.
9. Liu J, Li S, Zhang S, et al. Systemic immune-inflammation index (SII) definition and related CBC indices. 2019.
10. Mammadova A, et al. Systemic inflammation indices (including SII) elevated in COPD. 2025.
11. Schønberg-Moe A, et al. Platelet count and PLR associated with mortality in COPD. 2024.
12. Song Y, et al. Association of systemic immune-inflammation index with COPD severity. 2024.
13. World Health Organization. Chronic obstructive pulmonary disease (COPD) (fact sheet; updated Nov 6, 2024).
14. World Health Organization. The top 10 causes of death (fact sheet; updated Aug 2024).
15. Zinellu A, et al. Systematic review/meta-analysis: NLR and adverse outcomes in COPD. 2022.
